Home Tags Acquisition
Nvidia's strategic acquisition of Mellanox Technologies will help the chipmaker grab a share of the data-center market, a chip expert says.
The $6.5 billion acquisition that everyone hated a year ago was the only thing everyone loved about Salesforce’s latest quarter
Salesforce announced it would acquire MuleSoft nearly a year ago. Here's how much revenue MuleSoft generated and why Salesforce sees potential in it.
Google Cloud CEO Thomas Kurian spoke last week about plans to focus on enterprise customers. Now Google Cloud will acquire the Israeli startup Alooma.
Marc Benioff says that before Salesforce buys a startup, he does ‘due diligence’ on a company’s culture and how it pays employees
Salesforce co-CEO Marc Benioff addressed sexual harassment and equal pay in Silicon Valley, including the walkouts at Google last November.
Microsoft acquired open source database startup Citus Data. Here's why investing in open source could help Microsoft Azure edge out Amazon.
Aphria is urging shareholders to hold off on making any decisions about Green Growth Brands’ takeover bid
Aphria is down 1.13% early Wednesday after the company urged its shareholders to take no action on Green Growth Brands' hostile takeover bid.
The cannabis producer Tilray is gaining ground after announcing plans to acquire cultivator Natura Naturals
Canadian marijuana-producer Tilray was up almost 2% Tuesday after announcing plans to acquire cannabis cultivator Natura Naturals.
Switzerland’s Veeam Software just scooped up half a billion dollars in funding and the cofounder says he’s ready to start buying companies...
Veeam Software just closed $500 million from Insight Venture Partners, and it's currently looking into small companies to acquire later this year.
GitHub makes its first major move since Microsoft bought it for $7.5 billion — and it’s something customers have long been asking for
GitHub has launched free, private code repositories — something that customers have long been asking for.
Pharma giant Eli Lilly just made an $8 billion bet on a cutting-edge scientific approach that uses DNA to treat cancer
Eli Lilly's $8 billion acquisition of the biotech company Loxo Oncology is a notably large deal, but it's open to additional ones, its CEO said.